ID
32642
Beschrijving
A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT; ODM derived from: https://clinicaltrials.gov/show/NCT00751842
Link
https://clinicaltrials.gov/show/NCT00751842
Trefwoorden
Versies (1)
- 09-11-18 09-11-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
9 november 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Type 1 Diabetes Mellitus NCT00751842
Eligibility Type 1 Diabetes Mellitus NCT00751842
- StudyEvent: Eligibility
Similar models
Eligibility Type 1 Diabetes Mellitus NCT00751842
- StudyEvent: Eligibility
C0872146 (UMLS CUI [1,2])
C3163633 (UMLS CUI [1,2])
C1542147 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0021641 (UMLS CUI [3,2])
C0019693 (UMLS CUI [2])
C0019158 (UMLS CUI [3])
C0014544 (UMLS CUI [4])
C0018674 (UMLS CUI [5])
C0027765 (UMLS CUI [6])
C0038454 (UMLS CUI [7])
C0038586 (UMLS CUI [8])
C1705847 (UMLS CUI [2,1])
C0021403 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,1])
C0220806 (UMLS CUI [2,2])
C0032992 (UMLS CUI [2])
C0205404 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C1512714 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C1512714 (UMLS CUI [2,4])